Cost-Consequence Analysis of Using Neurofarmagen In The Decision-Making Process During The Treatment of Patients With Depression In The U.S
Oct 1, 2017, 00:00 AM
10.1016/j.jval.2017.08.1891
https://www.valueinhealthjournal.com/article/S1098-3015(17)32225-8/fulltext
Section Title :
Disease-Specific Studies
Section Order :
1719
First Page :
A713
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(17)32225-8&doi=10.1016/j.jval.2017.08.1891